dementia
Conditions
Interventions
To devide participants into 2 groups, administer to each group the test food containing 0.5mg or 1.0mg of plasmalogen for 3 months and observe the changes of MMSE and caretakers'
evaluation
Sponsors
Plasmalogens Research Society
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Informed consents are obtained in writing from patients or one of their caretakers 2.Those who regularly go to hospitals conducting this study and are 60 or older and 85 or younger Japanese (as of obtaining informed consent) 3.Those who showed 19 or less of Mini Mental State Examination at the beginning of this study 4.Those who are judged as suitable for participation in this study by responsible doctors at the beginning of the study
Exclusion criteria
Exclusion criteria: 1. Those who have scallop allergy 2. Those who are judged as not suitable for participation in this study by responsible doctors at the beginning of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function test (Mini Mental State Examination) | — |
Secondary
| Measure | Time frame |
|---|---|
| Caretakers' objective evaluation | — |
Countries
Japan
Contacts
Public ContactChikako Wakana
Plasmalogens Research Society General Manager
Outcome results
None listed